Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 210

1.

The current status of treatment-related severe hypoglycemia in Japanese patients with diabetes mellitus: a report from the committee on a survey of severe hypoglycemia in the Japan Diabetes Society.

Namba M, Iwakura T, Nishimura R, Akazawa K, Matsuhisa M, Atsumi Y, Satoh J, Yamauchi T; Japan Diabetes Society (JDS) Committee for Surveys on Severe Hypoglycemia.

Diabetol Int. 2018 Mar 2;9(2):84-99. doi: 10.1007/s13340-018-0346-2. eCollection 2018 May.

PMID:
30603355
2.

New risk factors of severe hypoglycemia.

Matsuhisa M, Kuroda A.

J Diabetes Investig. 2018 Sep 2. doi: 10.1111/jdi.12925. [Epub ahead of print] No abstract available.

3.

Up-Titration Strategy After DPP-4 Inhibitor-Based Oral Therapy for Type 2 Diabetes: A Randomized Controlled Trial Shifting to a Single-Dose GLP-1 Enhancer Versus Adding a Variable Basal Insulin Algorithm.

Miyagi M, Uchino H, Kumashiro N, Higa M, Shin K, Sasamoto M, Kitazato H, Tamaki M, Matsuhisa M, Hirose T.

Diabetes Ther. 2018 Oct;9(5):1959-1968. doi: 10.1007/s13300-018-0486-1. Epub 2018 Aug 18.

4.

The current status of treatment-related severe hypoglycemia in Japanese patients with diabetes mellitus: A report from the committee on a survey of severe hypoglycemia in the Japan Diabetes Society.

Namba M, Iwakura T, Nishimura R, Akazawa K, Matsuhisa M, Atsumi Y, Satoh J, Yamauchi T; Japan Diabetes Society (JDS) Committee for Surveys on Severe Hypoglycemia.

J Diabetes Investig. 2018 Mar 2. doi: 10.1111/jdi.12790. [Epub ahead of print]

5.

Predictors for the Treatment Effect of Sodium Glucose Co-transporter 2 Inhibitors in Patients with Type 2 Diabetes Mellitus.

Yagi S, Aihara KI, Kondo T, Kurahashi K, Yoshida S, Endo I, Fukuda D, Nakaya Y, Suwaki KI, Takeji T, Wada T, Salim HM, Hama S, Matsuura T, Ise T, Kusunose K, Yamaguchi K, Tobiume T, Yamada H, Soeki T, Wakatsuki T, Matsuhisa M, Shimabukuro M, Akaike M, Sata M.

Adv Ther. 2018 Jan;35(1):124-134. doi: 10.1007/s12325-017-0639-z. Epub 2017 Nov 28.

PMID:
29185199
6.

Safety of the batteries and power units used in insulin pumps: A pilot cross-sectional study by the Association for the Study of Innovative Diabetes Treatment in Japan.

Murata T, Nirengi S, Sakane N, Kuroda A, Hirota Y, Matsuhisa M, Namba M, Kobayashi T; Association for the Study of Innovative Diabetes Treatment in Japan (ASINDTJ).

J Diabetes Investig. 2018 Jul;9(4):903-907. doi: 10.1111/jdi.12765. Epub 2017 Nov 28.

7.

Accuracy and Time Delay of Glucose Measurements of Continuous Glucose Monitoring and Bedside Artificial Pancreas During Hyperglycemic and Euglycemic Hyperinsulinemic Glucose Clamp Study.

Kuroda A, Taniguchi S, Akehi Y, Mori H, Tamaki M, Suzuki R, Otsuka Y, Matsuhisa M.

J Diabetes Sci Technol. 2017 Nov;11(6):1096-1100. doi: 10.1177/1932296817735122. Epub 2017 Oct 9.

8.

Remarkable Shrinkage of a Growth Hormone (GH)-secreting Macroadenoma Induced by Somatostatin Analogue Administration: A Case Report and Literature Review.

Kurahashi K, Endo I, Kondo T, Morimoto K, Yoshida S, Kuroda A, Aihara KI, Matsuhisa M, Nakajima K, Mizobuchi Y, Nagahiro S, Abe M, Fukumoto S.

Intern Med. 2017 Sep 15;56(18):2455-2461. doi: 10.2169/internalmedicine.8223-16. Epub 2017 Aug 21.

9.

Effect of sitagliptin on the echocardiographic parameters of left ventricular diastolic function in patients with type 2 diabetes: a subgroup analysis of the PROLOGUE study.

Yamada H, Tanaka A, Kusunose K, Amano R, Matsuhisa M, Daida H, Ito M, Tsutsui H, Nanasato M, Kamiya H, Bando YK, Odawara M, Yoshida H, Murohara T, Sata M, Node K; PROLOGUE Study Investigators.

Cardiovasc Diabetol. 2017 May 11;16(1):63. doi: 10.1186/s12933-017-0546-2.

10.

Suppression of the Hypothalamic-pituitary-adrenal Axis by Maximum Androgen Blockade in a Patient with Prostate Cancer.

Kondo T, Endo I, Ooguro Y, Morimoto K, Kurahashi K, Yoshida S, Kuroda A, Aihara KI, Matsuhisa M, Abe M, Fukumoto S.

Intern Med. 2016;55(24):3623-3626. Epub 2016 Dec 15.

11.

Sustained glycaemic control and less nocturnal hypoglycaemia with insulin glargine 300U/mL compared with glargine 100U/mL in Japanese adults with type 1 diabetes (EDITION JP 1 randomised 12-month trial including 6-month extension).

Matsuhisa M, Koyama M, Cheng X, Sumi M, Riddle MC, Bolli GB, Hirose T; EDITION JP 1 study group.

Diabetes Res Clin Pract. 2016 Dec;122:133-140. doi: 10.1016/j.diabres.2016.10.002. Epub 2016 Oct 13.

PMID:
27835765
12.

Impact of glycemic control with sitagliptin on the 2-year progression of arterial stiffness: a sub-analysis of the PROLOGUE study.

Tomiyama H, Miwa T, Kan K, Matsuhisa M, Kamiya H, Nanasato M, Kitano T, Sano H, Ohno J, Iida M, Sata M, Yamada H, Maemura K, Tanaka A, Murohara T, Node K.

Cardiovasc Diabetol. 2016 Nov 3;15(1):150.

13.

Enhancement of anodic current attributed to oxygen evolution on α-Fe2O3 electrode by microwave oscillating electric field.

Kishimoto F, Matsuhisa M, Kawamura S, Fujii S, Tsubaki S, Maitani MM, Suzuki E, Wada Y.

Sci Rep. 2016 Oct 14;6:35554. doi: 10.1038/srep35554.

14.

A pilot study comparing the CGM-assessed glycemic profiles of patients with type 1 diabetes on insulin degludec and insulin glargine.

Kuroda A, Tsuruo M, Aki N, Kondo T, Oguro Y, Tamaki M, Aihara KI, Endo I, Matsumoto T, Abe M, Matsuhisa M.

Diabetol Int. 2016 Oct 14;8(1):112-115. doi: 10.1007/s13340-016-0289-4. eCollection 2017 Mar.

15.

Advanced glycation end-products are a risk for muscle weakness in Japanese patients with type 1 diabetes.

Mori H, Kuroda A, Araki M, Suzuki R, Taniguchi S, Tamaki M, Akehi Y, Matsuhisa M.

J Diabetes Investig. 2017 May;8(3):377-382. doi: 10.1111/jdi.12582. Epub 2016 Nov 23.

16.

Sequential cleavage of insulin receptor by calpain 2 and γ-secretase impairs insulin signalling.

Yuasa T, Amo-Shiinoki K, Ishikura S, Takahara M, Matsuoka T, Kaneto H, Kuroda A, Matsuhisa M, Hashida S.

Diabetologia. 2016 Dec;59(12):2711-2721. Epub 2016 Sep 30.

PMID:
27695899
17.

Somatic cell reprogramming-free generation of genetically modified pigs.

Tanihara F, Takemoto T, Kitagawa E, Rao S, Do LT, Onishi A, Yamashita Y, Kosugi C, Suzuki H, Sembon S, Suzuki S, Nakai M, Hashimoto M, Yasue A, Matsuhisa M, Noji S, Fujimura T, Fuchimoto D, Otoi T.

Sci Adv. 2016 Sep 14;2(9):e1600803. doi: 10.1126/sciadv.1600803. eCollection 2016 Sep.

18.

Rationale and design of a multicenter randomized controlled study to evaluate the preventive effect of ipragliflozin on carotid atherosclerosis: the PROTECT study.

Tanaka A, Murohara T, Taguchi I, Eguchi K, Suzuki M, Kitakaze M, Sato Y, Ishizu T, Higashi Y, Yamada H, Nanasato M, Shimabukuro M, Teragawa H, Ueda S, Kodera S, Matsuhisa M, Kadokami T, Kario K, Nishio Y, Inoue T, Maemura K, Oyama J, Ohishi M, Sata M, Tomiyama H, Node K; PROTECT Study Investigators.

Cardiovasc Diabetol. 2016 Sep 13;15(1):133. doi: 10.1186/s12933-016-0449-7.

19.

Skin Autofluorescence is Associated with Early-stage Atherosclerosis in Patients with Type 1 Diabetes.

Osawa S, Katakami N, Kuroda A, Takahara M, Sakamoto F, Kawamori D, Matsuoka T, Matsuhisa M, Shimomura I.

J Atheroscler Thromb. 2017 Mar 1;24(3):312-326. doi: 10.5551/jat.35592. Epub 2016 Sep 2.

20.

Strict blood glucose control by an artificial endocrine pancreas during hepatectomy may prevent postoperative acute kidney injury.

Mita N, Kawahito S, Soga T, Takaishi K, Kitahata H, Matsuhisa M, Shimada M, Kinoshita H, Tsutsumi YM, Tanaka K.

J Artif Organs. 2017 Mar;20(1):76-83. doi: 10.1007/s10047-016-0925-6. Epub 2016 Aug 24.

PMID:
27557726

Supplemental Content

Loading ...
Support Center